Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880581 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
A Phase 2 study, sponsored by Ronald Levy.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00880581 is a Phase 2 study that has completed, run by Ronald Levy. The registered enrollment target is 30 participants.
The verdict
NCT00880581, a Phase 2 study, has completed, sponsored by Ronald Levy.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
To assess the feasibility of using intra-tumoral PF-3512676 in combination with local radiation as a therapy for lowgrade b-cell lymphoma.
Interventions
- DRUG PF-3512676
- RADIATION Local radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00880581
The ClinicalTrials.gov registry entry for NCT00880581 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ronald Levy, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PF-3512676 is the first listed.
NCT00880581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00880581 about?
NCT00880581 is a clinical study titled "A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas". To assess the feasibility of using intra-tumoral PF-3512676 in combination with local radiation as a therapy for lowgrade b-cell lymphoma.
What is the current status of trial NCT00880581?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2009-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00880581?
The interventions under investigation include: PF-3512676 (DRUG), Local radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00880581?
This trial is sponsored by Ronald Levy, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.